The introduction of TAVR began an era of rapid change in the U.S. heart valve market, setting high expectations for other transcatheter valve devices currently in development.

View the infographic below to see how innovation has impacted market dynamics and brand share, including Edwards Lifesciences, Medtronic, and LivaNova.

Get more heart valve data and expertise specific to your brand, markets, and customers:

 

Incorporating the Voice of the Patient into Medtech Strategy

View Now